AbstractHIVINTEREST 2020Evaluation of Second Line Antiretroviral Programmatic and Treatment Outcomes in Mozambique between 2015-2017View Abstract
AbstractHIVINTEREST 2020Patient-reported reasons for missed appointments among ART patients in South AfricaView Abstract
AbstractHIVINTEREST 2020U=U - Catalyst or Barrier for Men's Engagement in ART? Stakeholder Views from Blantyre, MalawiView Abstract
AbstractHIVINTEREST 2020Impact of community resource persons and mobile phone technology on return to HIV care among loss to follow up HIV clients in 104 HIV facilities in UgandaView Abstract
AbstractHIVINTEREST 2020Switching to DTG/3TC Fixed-Dose Combination (FDC) Is Non-inferior to Continuing a TAF-Based Regimen Through 48 Weeks: Subgroup Analyses From the TANGO StudyView Abstract
AbstractHIVINTEREST 2020A Hybrid Interpersonal Training Model to build Capacity for Health-Care-Providers (HITCH) to Manage Children, Adolescents and Adults on Third-Line Anti-Retro Viral (ART) Therapy in Uganda.View Abstract
AbstractHIVINTEREST 2020Effectiveness of male Strategy (MS) in HIV case identification and linkage of MLHIV to treatment in Cameroon.View Abstract
AbstractHIVINTEREST 2020Doing Index Testing differently: A health education approach for old clients returning for refill and those newly initiating ART to effectively participate in index testing.View Abstract
AbstractHIVINTEREST 2020Dolutegravir- versus low-dose Efavirenz-based regimen for the initial treatment of HIV-1 infection in Cameroon: 96-week results of the ANRS 12313 – NAMSAL trialView Abstract
AbstractHIVINTEREST 2020Does Dolutegravir causes weight gain: a retrospective observational cohort study from Lusaka, ZambiaView Abstract
AbstractHIVINTEREST 2020DTG+3TC vs DTG+TDF/FTC (GEMINI-1&-2): Confirmed Virologic Withdrawals Through Week 96View Abstract
